Vor Bio to Participate in Upcoming Investor Conferences

CAMBRIDGE, Mass., June 01, 2022 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today announced that it will participate in the following upcoming investor conferences:

Jefferies Healthcare ConferencePresentation date: Wednesday, June 8, 2022Presentation time: 2:30 PM ETLocation: Marriott Marquis, New York, NY

Goldman Sachs 43rd Annual Global Healthcare Conference Dates: June 13-16, 20221x1 meetings onlyLocation: Terranea Resort, Ranch Palos Verdes, CA

JMP Securities Life Sciences ConferenceFireside Chat date: Thursday, June 16, 2022Presentation time: 11:00 AM ETLocation: The Lotte New York Palace Hotel, New York, NY

Stifel’s 2022 Virtual Cell Therapy SummitDates: June 29-30, 2022

Live webcasts and archived replays of key presentations will be available on the Company's website at https://ir.vorbio.com/news-and-events/events-and-presentations.

About Vor BioVor Bio is a clinical-stage cell and genome engineering company that aims to change the standard of care for patients with blood cancers by engineering hematopoietic stem cells to enable targeted therapies post-transplant. For more information, visit: www.vorbio.com.

Contact:Investors & MediaSarah Spencer +1 857-242-6076[email protected]

You May Also Be Interested In

• Arcee AI Announce Genesis-Science-1, an Open-Weight Model for Scientific Research
• PetMeds Announces Proposed Sale-Leaseback of Headquarters and Distribution Center Buildings for $37 Million
• Kavalan Named 'Whisky of the Year' For Second Year Running at IWC 2026